CN Patent
CN1835962A — 利用乙酰化二糖治疗疾病的组合物与方法
Assigned to University of California San Diego UCSD · Expires 2006-09-20 · 20y expired
What this patent protects
本发明提供了利用乙酰化二糖及其类似物来治疗疾病的组合物与方法。
USPTO Abstract
本发明提供了利用乙酰化二糖及其类似物来治疗疾病的组合物与方法。
Drugs covered by this patent
- Jardiance (empagliflozin) · Boehringer Ingelheim
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.